Re: Biologic characteristics of interval and screen-detected breast cancers [2]

Journal of the National Cancer Institute

Volumn 92, Issue 18, 2000, Pages 1533-1534

  Eisinger, François ^a   Juliain Reynier, Claire ^b   Sobol, Hagay ^a,b  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER SCREENING; FAMILIAL CANCER; FEMALE; FRANCE; GENE MUTATION; GENETIC RISK; HUMAN; LETTER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SCREENING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADULT; AGE FACTORS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; GENES, P53; GERM-LINE MUTATION; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RISK; TIME FACTORS; UP-REGULATION;

EID: 0034692431     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Biologic characteristics of interval and screen-detected breast cancers
2. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer
3. p53 involvement in BRCA1-associated breast cancer
4. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
5. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium
6. Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee
7. Acceptability of prophylactic mastectomy in cancer-prone women